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Abstract: For years, the consumption of a diet rich in fruits and vegetables has been considered
healthy, increasing longevity, and decreasing morbidities. With the assistance of basic research inves-
tigating the potential mechanisms, it has become clear that the beneficial effects of plant-based foods
are mainly due to the large amount of bioactive phenolic compounds contained. Indeed, substantial
dietary intervention studies in humans have supported that the supplementation of polyphenols
have various health-promoting effects, especially in the elderly population. In vitro examinations
on the anti-aging mechanisms of polyphenols have been widely performed, using different types
of natural and synthetic phenolic compounds. The aim of this review is to critically evaluate the
experimental evidence demonstrating the beneficial effects of polyphenols on aging-related diseases.
We highlight the potential anti-aging mechanisms of polyphenols, including antioxidant signaling,
preventing cellular senescence, targeting microRNA, influencing NO bioavailability, and promot-
ing mitochondrial function. While the trends on utilizing polyphenols in preventing aging-related
disorders are getting growing attention, we suggest the exploration of the beneficial effects of the
combination of multiple polyphenols or polyphenol-rich foods, as this would be more physiologically
relevant to daily life.
Keywords: polyphenol; aging; antioxidant; cellular senescence
1. Introduction
The common understanding of food has evolved from the previous concept “eat to
live” to health promotion and disease prevention. Substantial dietary intervention studies
and epidemiological surveys have demonstrated that the consumption of a diet rich in
fruits and vegetables has health-promoting effects [1,2]. It is estimated that the proportion
of people aged 60 and above will increase from 12% in 2015 to 22% in 2050 [3]. Thus,
delaying or preventing the onset of aging-related diseases due to cellular damage and
functional decline would greatly improve life quality and expectancy, as well as mitigate
the burden on the current healthcare system.
Despite the debate on the free radical theory of aging for the past decade [4], it is widely
acknowledged that disrupted homeostasis between oxidants and antioxidants would cause
cellular damage and even organ dysfunction [5]. To counteract the abnormal oxidative
stress and accumulation of excess oxidants such as reactive oxygen species (ROS), which
cause DNA damage [6] and cellular senescence [7], antioxidants bind to the pro-oxidants
and abstract hydrogen to form stabilized radicals, hence neutralizing the hazardous effects
of oxidants [8]. Oxidative stress plays an important role in aging process and various
aging-associated chronic diseases. Reducing ROS has been shown to alleviate oxidative
damage and extend the lifespan of various animal species [9]. Thus, phytonutrients with
antioxidant property have drawn great attention for their ROS-scavenging actions and
anti-aging potential.
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Polyphenols are the largest, most studied group of naturally occurring antioxidants,
which can be structurally categorized into phenolic acids, flavonoids, stilbenes, lignans,
and other polyphenols with hydroxyl group(s) attached to the carbon atom on the aromatic
ring (detailed classification and their food sources are listed in Table 1) [10]. It was reported
that dietary consumption of polyphenols is much higher than the daily intake of several
essential micronutrients, such as vitamin C, vitamin E, and carotenoids [11]. Over the
past two decades, polyphenolic compounds have attracted considerable research interests
because of their wide distribution in different foods and their potent antioxidant prop-
erties [11]. In addition, polyphenols were reported to modulate energy metabolism in a
manner favorable for well-being and longevity and reduce the risk of aging-related chronic
diseases [12–15]. Here, we provide a brief overview of the current understanding of aging
and the mechanisms of cellular senescence. We propose to critically review the anti-aging
effects of polyphenols and experimental evidence supporting the health-promoting effects
against aging-related diseases.
Table 1. Classification of polyphenols and dietary sources.
Classification Subgroups Dietary Sources
Phenolic acids Hydroxybenzoic acids
Wine, sorghum, dried date,
blackberry, apple juice, olive,
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2. Anti-Aging Effects of Polyphenols
2.1. Polyphenols and Longevity
There has been great interest in identifying natural compounds for improving health,
preventing chronic diseases, and extending longevity. In this regard, numerous polyphe-
nols, including EGCG, curcumin, and quercetin, have been shown to extend lifespan in
various model organisms, including Caenorhabditis elegans (C.elegan), Drosophila Melanogaster
(Drosophila), as well as high-fat diet-induced obese rodents [15]. Similarly, dietary resver-
atrol was shown to promote the health and survival of high-fat diet-induced obese male
mice [16]. However, resveratrol treatment failed to extend the lifespan of chow-diet fed
C57/B6 mice [17] or heterozygous mice [18,19]. In an animal study, Reutzel et al. reported
that administering a mixture of six highly purified olive secoiridoid polyphenols at 50 mg
/kg in the diet for six months has a long-term positive effect on cognition and brain energy
metabolism in aging mice [20]. In this study, cognition was measured by behavioral tests.
Brain ATP level and NADH reductase, cytochrome c oxidase, and citrate synthase mRNA
expression levels are the main indicators for mitochondrial dysfunction [20]. Moreover,
data from the Aging Intervention Testing Program supported by the National Institute
on Aging (USA) showed that the popular anti-aging natural agents, including resvera-
trol, green tea extract, and curcumin did not affect lifespan of standard chow-diet-fed
heterozygous mice [19]. These results suggest that these compounds may only work under
certain conditions. In that regard, they may only delay or mitigate aging-associated chronic
diseases in inbred mice fed a high-fat diet for a long period of time, which lack genetic
diversity and are more susceptible to environment insult-induced pathological changes.
We found that dietary intake of (-)-epicatechin (EC), a flavonoid present in various
foods including cocoa (Theobroma cacao), chocolate, berries, and tea, greatly increased
survival rate in obese diabetic mice (50% and 8.4% mortality in control and EC groups after
15 weeks of treatment, respectively), whereas blood glucose levels and food intake were not
modulated, suggesting that the observed effects of EC was not due to the secondary action
to the changes of these variables. However, EC treatment improved skeletal muscle stress,
reduced systematic inflammation, increased hepatic antioxidant glutathione concentration
and superoxide dismutase activity, decreased circulating insulin-like growth factor-1, and
improved AMP-activated protein kinase-α activity in the liver and skeletal muscle of
diabetic mice. Therefore, EC may be a novel food-derived, anti-aging compound with
direct lifespan-extending effect, given that these favorable changes are always associated
with a healthier and longer lifespan [21]. Consistently, further study showed that EC
(0.1–8 mmol/L) also promoted survival and increased mean lifespan of Drosophila [21].
To further examine whether EC indeed is able to promote health and lifespan in aged
but otherwise healthy mice fed the standard chow diet, we provided 20-month old mice
(equivalent of 60-65 years old in humans) with EC in drinking water (0.25% w/v) for
37 weeks, and discovered that EC-treated mice had a strikingly higher survival rate as
compared with that in control group (69.7% versus 39.2%) [22]. Remarkably, the universal
profiles of the serum metabolites and general mRNA expressions in skeletal muscle of old
mice were shifted by EC toward those demonstrated in young mice [22]. These findings
suggest that EC may be a novel anti-aging polyphenolic compound that could promote
healthy lifespan in normal healthy subjects. Cocoa is particularly rich in flavonoids that
include EC, flavanol-3ols, catechin, and oligomeric derivatives, making up 10% of the
dry weight of cocoa powder [23–26]. Thus, it is tempting to speculate that cocoa product
consumption may extend the lifespan in humans. Epidemiological studies further show
that people living on the San Blas Island, who are known to consume large amounts
of cocoa beverage daily, have a remarkably longer lifespan than those who live in the
mainland of Panama [27,28]. Interestingly, these differences disappeared when people
from San Blas island migrated to Panama city where cocoa consumption was considerably
reduced [29]. Dietary chocolate intake extended average life expectancy by as much as
4 years in humans [30]. While EC only accounts for 20–30% of total flavanols in cocoa, its
oligomers cannot be absorbed into circulation in rodents and humans [23–25]. Therefore, it
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is believed that the monomers might be the predominant form responsible for the beneficial
effects of cocoa in vivo. Indeed, EC was found to be the dominant (>96%) flavanol in
human circulation with the plasma concentration reaching more than 6 µM after ingestion
of cocoa [31]. Therefore, EC may be the primary constituent in cocoa that exerts health
benefits and extends lifespan in healthy subjects.
Data from both epidemiological and large randomized clinical studies have demon-
strated that Mediterranean diet (MeD) eating pattern was associated with lower risk of
major chronic diseases (heart disease, cognitive decline and breast cancer), better quality
of life, and longer life expectancy [32]. A 50-year follow-up study found that MeD eating
habit contributes 4.4 years longer of life expectancy in Italy [33], which is similar to other
two intervention studies showing that MeD is inversely associated with total mortality in
Sweden [34] and the USA [35]. While Mediterranean dietary pattern is characterized by con-
sumption of plant-based foods and olive oil, which may collectively exert health-promoting
effects, emerging evidence shows that some polyphenols present in olive and olive oil
likely contribute to some observed health benefits of Mediterranean diet consumption.
Indeed, olive-derived polyphenols, including hydroxytyrosol, tyrosol, oleuropein, and
pinoresionol [36,37], were reported to improve aging-related dysfunctions of the brain [38],
and heart [39] in mice. Long-term (10 months) dietary intake of extra-virgin olive oil
(10% wt/wt dry diet) rich in phenols (total polyphenol dose/day, 6 mg/kg) significantly
prevented aging-related impairment in motor coordination in the rotarod test in 10-month
old C57BL/6J mice [38]. Dietary intake of 10% olive oil (contains 532 mg gallic acid/kg
oil) for 4.5 months significantly reduced oxidative stress in the senescence-accelerated
mouse prone 8 (SAMP8) mice, which was mediated by the induction of nuclear factor
erythroid 2-related factor 2 (Nrf2)-dependent gene expressions [39]. These results are in
line with a new report that dietary intake of extra virgin olive oil for 6 months significantly
ameliorated cognition decline in a transgenic mouse model with brain amyloid plaques
and neurofibrillary tangles [40]. In a study with diabetic rats, it was also shown that a
3-month treatment with virgin olive oil (0.125 mg/kg phenols per day) displayed a stronger
neuroprotective ability than that of aspirin (2 mg/kg per day) [41]. Although the mortality
rate was not altered by olive oil intake because of the relatively young age of the mice used
in these studies (10-months or 9–10 weeks old), it is tempting to speculate that olive oil
polyphenols might have the potential to extend lifespan. Actually, increasing evidence
supports that olive oil phenols delay the aging process in cells, animals, and humans [42,43].
Rechtsregulat®(RR) is the fruit and vegetable extract that is rich in polyphenols, including
phenolic metabolites such as protocatechuic acid (PCA) [44]. Dilberger et al. reported that
C. elegans administrated with 10% RR or 780 µM PCA showed a significant increase in
heat-stress resistance, median lifespan, and activity of mitochondrial respiratory chain
complexes. These results suggest that both polyphenols and the PCA can enhance the
lifespan and mitochondrial function [44]. The European Food Safety Authority has ap-
proved a claim that olive oil polyphenols protect against LDL oxidation at a minimal dose
of 5 mg/kg/day hydroxytyrosol [45].
2.2. Polyphenols on Aging-Related Diseases
Aging is a well-established risk factor for a wide range of diseases [15], among which
neurodegenerative diseases are highly prevalent since the central nervous system (CNS) is
vulnerable to aging-induced cellular malfunction and degenerative damage [46]. In addi-
tion, cellular inflammatory response progressively increases with age [47], which increases
the risk for developing chronic inflammation related disease such as atherosclerosis in the
elderly [48]. Furthermore, type 2 diabetes (T2D), characterized by insulin resistance and
pancreatic β-cell dysfunction, may lead to a complex complications such as vascular tissue
damage, depression, cognitive decline, and dementia which are tightly associated with ag-
ing [13]. Below we will review studies, mostly in vivo studies, exploring the physiological
role of polyphenols in aging-related disease. We aim to critically review the studies using
polyphenols as a complementary and alternative medicine that benefits humans.
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2.2.1. Polyphenols in Neurodegenerative Diseases
Aging is a major risk factor for developing neurodegenerative diseases, and presently,
there is no effective treatment for aging-related neurodegeneration [49]. Neurodegenerative
diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease
(HD), and amyotrophic lateral sclerosis (ALS), are characterized by the progressive loss of
functional neuron cells [50]. The brain requires comparably high amount of oxygen [51]
and the impaired oxidative balance in the brain has been substantially determined as the
common feature of neurodegenerative diseases [52,53]. Mounting research have reported
the utilization of natural polyphenols on neurodegenerative diseases due to their antioxi-
dant and anti-aging properties [54–58]. Grape is an evident example of fruits that contain
a high content of polyphenols [59]. Dietary supplement of grape polyphenol concentrate
at 1.5 mL/kg significantly enhanced memory reconsolidation in transgenic mouse model
of PD [60]. Curcumin is a polyphenol present in turmeric (Curcuma longa) root, which
is a yellow pigment used in curry. In an old aluminum-induced neurotoxical rat model,
oral gavage of 30 mg/ml/kg curcumin treatment significantly suppressed the activities
of superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione-s-transferase
(GST), protein kinase C (PKC), and Na+, K+-ATPase, thereby protecting the brain against
aluminum toxicity in aging rats [61]. Supplementation of EC (10 mg/kg) per day for
two weeks significantly ameliorated 6-hydroxydopamine (OHDA)-lesioned PD behavior,
including increased locomotor activity and decreased rotational behavior, as compared
with sham operated control group in male rats, suggesting a neuroprotective property of
this compound [62]. Sugarcane (Saccharum officinarum L.) top ethanolic extract was reported
to contain several polyphenols with strong antioxidant effects, including 3-caffeoylquinic
acid (CQA), 5-CQA, 3-O-feruloylquinic acid (FQA), and isoorientin [63]. CQA provided at
5 mg/kg for 30 days was reported to enhance brain function of SAMP8 mice as demon-
strated in the Morris water maze test [64]. Consistently, microarray analysis showed
that sugarcane top ethanolic extract regulated neuron development-associated genes in
the cerebral cortex of SAMP8 mice [63]. Isoorientin is a naturally occurring C-glycosyl
flavone and exists in several dietary plants, including corn silks [65], rooibos tea [66],
and buckwheat [67]. Interestingly, although isoorientin showed lower antimycobacterial
activity in virulent strain [68], it remarkably protected human neuroblastoma SH-SY5Y
cells from 6-OHDA-induced toxicity via the AMPK/Akt/Nrf2 signaling pathway [69].
Olive polyphenols are components of the Mediterranean diet. Grewal et al. examined the
effects of purified olive secoiridoid derivatives and their metabolites on mitochondrial
function in SH-SY5Y-APP695 cells, a cellular model of early AD [70]. An aging mouse
model (Female NMRI mice, aged 12 months) was used to further examine the effects
of purified secoiridoids (oleocanthal and ligstroside) in vivo. Results of in vitro studies
showed that purified ligstroside protected against mitochondrial dysfunction by restoring
ATP levels in models of early AD [70]. Female NMRI mice supplemented with oleocanthal
or ligstroside (6.25 mg/kg b.w) for six months showed improved spatial working memory
and ATP levels in the brain [70]. These results indicate that ligstroside can expand the
lifespan in aging mice and enhance cognitive function. The ortho-diphenol hydroxytyrosol
(HT) is one of the main components of extra virgin olive oil, which is an important part
of the Mediterranean diet. Schaffer et al. reported that HT-rich olive mill wastewater
extract (HT-E) and its main constituent HT were found to protect against ferrous iron or
sodium nitroprusside-induced cytotoxicity in PC 12 neuronal cells [71]. The same group
further demonstrated that HT-E also protects isolated brain cells against oxidative stress
after subchronic oral administration of the extract to mice, suggesting the neuroprotective
potential of HT-E [72]. The flavonoid 7,8-dihydroxyflavone (7,8-DHF) is one of the polyphe-
nolic compounds and is naturally present in Godmania aesculifolia, Tridax procumbens, and
in leaves of Primroses [73]. Rho proteins, including the small GTPase Rac1 are essential
regulators of neuronal synaptic plasticity. Interestingly, the levels of Rac1 and Rab3A were
restored in membrane isolated from brains of aged mice when treated with 7,8-DHF at
100 mg /kg body weight once daily for a total of 21 days via oral gavage [73]. Quercetin
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is one of the polyphenols found in many foods and vegetables, such as red wine, green
tea, apples, and berries. Quercetin at 1 µM was found to prevent glucose-induced lifespan
reduction of C. elegans mev-1 mutants [74]. The results of this study further demonstrated
that the sirtuin SIR-2.1, the nuclear hormone receptor DAF-12, and MDT-15 are essential
for the effect of quercetin [74].
Although the etiology of AD is still elusive, the production of amyloid β (Aβ) pep-
tides via β-secretase and γ-secretase cleavage are the pathological hallmarks of AD [75]. In
addition, abnormal phosphorylation and aggregation of tau protein in neuronal cells also
lead to the progression of AD [76]. As mentioned above, isoorientin is a naturally occurring
polyphenol with strong antioxidant property and it has been demonstrated to protect
human neuroblastoma SH-SY5Y cells from β-amyloid induced tau hyperphosphorylation,
thereby exerting neuroprotective potential [65]. Treatment with green tea polyphenols
significantly protected primary rat prefrontal cortical neuron cells from Aβ-induced neu-
rotoxicity via the protein kinase B (PKB, also known as Akt) signaling pathway [77]. In
addition to green tea, coffee is also a popular beverage worldwide. Epidemiological stud-
ies have shown the lifespan-extending benefits of coffee-consuming habits [78] and the
potential of coffee consumption in alleviating the severity of PD [79]. Chlorogenic acid
largely presents in both caffeinated and decaffeinated coffee, with a potent free radical
scavenging activity and antioxidant effects [80]. Treatment of chlorogenic acid (40 mg/kg
bw) significantly improved spatial memory in the Morris water maize test and alleviated
neuron damage in an AD mouse model [81]. The biosynthetic compound 3’-O-methyl-
epicatechin-5-O-β-glucuronide, which is a grape derived polyphenol, improved basal
synaptic transmission and cognitive functions in a mouse model of AD [82]. Catechins
are a group of bioactive polyphenols found in green tea leaves, among which (+)-catechin,
EC, and (-)-epigallocatechin gallate (EGCG) are the most abundant and well-known com-
pounds [83]. These polyphenols also can be found in other fruits and vegetables such
as cocoa beans and berries [84]. In a mice model with an early appearance of learning
and memory decline and an increased production of Aβ peptides, 0.05–0.1% catechin
treatment decreased Aβ peptides and enhanced mice behavior in spatial learning and
memory capacity tests [85]. As aforementioned, resveratrol was quite a hot topic among
scientists because of the “French Paradox” a decade ago. A comprehensive review pa-
per summarized that resveratrol extends model organisms life expectancy by up to 60%
depending on the dosage, gender, genetic background, and diet composition [86]. In an
intracerebroventricular injection of streptozotocin-induced brain insulin resistant rat model,
30 mg/kg/day resveratrol treatment significantly increased brain Sirt1 activity, reversed
the hyperphosphorylation of tau, and enhanced the cognitive capability as compared with
age-matched control rats [87]. The pathophysiology of neurodegenerative diseases has a
complex mechanism and as the elderly population gets larger, aging-related neurodegener-
ative diseases become a major worldwide public health concern. The available in vivo and
in vitro studies indicate a possible role of polyphenols in improving cognitive function and
neurodegenerative diseases, future clinical trials are needed to assess the possibility using
natural polyphenols as a therapeutic strategy.
2.2.2. Polyphenols in Aging-Related Inflammatory Diseases
Despite the enormous complexity of aging, one of the key features is chronic inflamma-
tion [88]. A recent retrospective study testing the effects of resveratrol in AD patients (aged
50 and above) reported that 52 weeks of resveratrol treatment (1 g by mouth twice daily)
significantly decreased levels of plasma inflammatory markers and induced the adaptive
immune response, suggesting a promising role of resveratrol against inflammation [89].
Nuclear factor kappa light chain enhancer of activated B cells (NF-κB) is a ubiquitous
transcription factor, which can be activated by acetylation and phosphorylation, thereby
initiates the transcriptional cascade of a large variety of target genes that are involved in
inflammation and innate immunity in mammalian cells [90]. EGCG, the major polyphe-
nol found in green tea, was reported to extend rat median lifespan from 92.5 weeks to
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105 weeks and significantly decrease the mRNA and protein levels of NF-κB, improving
aging-induced oxidative status in rat liver and kidney [91]. In a randomized controlled
clinical trial, consumption of turmeric extracts curcumin at 1.5 g/day for four weeks al-
leviated pain and swelling with minimal side effects in osteoarthritis patients (aged 50
and above) [92]. Similarly, quercetin, one of the most studied polyphenol found in various
fruits [93], efficiently reduced the severity and sickness period in older patients with upper
respiratory tract infection at a dose of 1 g per day for 12 weeks [94]. Treatment of isoorientin
effectively inhibited the release of inflammatory cytokines in high fructose-fed mice [95].
Recently, we reported for the first time that curcumin (1 µM) and luteolin (0.5 µM) synergis-
tically (combination index is 0.60) inhibited TNF-α-induced monocyte adhesion to human
EA.hy926 endothelial cells while the individual chemicals did not have such effect at the
selected concentrations [96]. Collectively, studies in both humans and animals have shown
the potential of polyphenols in modulating aging-related inflammatory disorders and
further analyses of the detailed mechanisms can be useful to guide clinicians and health
care providers to consider polyphenols in their approach to intervene aging-associated
inflammatory responses.
3. Potential Anti-Aging Mechanisms
3.1. The Antioxidant Effects of Polyphenols
According to the free radical theory, aging results from chronic imbalance (extra
amount of ROS) between ROS and antioxidants, also called oxidative stress, which leads to
cellular senescence, functional alterations, and pathological conditions [97,98] as discussed
above. It has been well acknowledged that many polyphenolic compounds possess antioxi-
dant properties. As exogenous antioxidants, polyphenols can combat ROS by at least four
mechanisms as highlighted below.
First, polyphenols can directly scavenge ROS because of the presence of phenolic hy-
droxyl groups on their molecules. The ROS-scavenging capacity of polyphenols depends on
the number and position of the hydroxyl group and substituent patterns, as well as glycosy-
lation of phytochemical molecules [99–101]. For example, kaempherol-3,7,4’-trimethylether,
kaempherol-3,4’-dimethylether, kaempherol-7-neohesperidoside, and kaempherol, which
have 1 (in the 5-position), 2, 3, and 4 hydroxyl substitutions, respectively, are 0, 1.0, 1.6, and
2.7 times of trolox equivalent antioxidant activity, respectively [102]. These data suggest
that phenolic compounds with more hydroxyl groups may have a stronger antioxidant
capacity. Moreover, substitution patterns in the B-ring and A-ring as well as the 2, 3-double
bond (unsaturation) and the 4-oxo group in the C-ring are important for the antioxidant
capacity of the compounds [103,104]. Polyphenol with a 3′,4′-o-dihydroxyl group in the
B-ring, a 2,3-double bond combined with a 4-keto group in the C-ring, and a 3-hydroxyl
group had the highest antioxidant activity [103,105]. Flavanols with a galloyl moiety had
higher antioxidant activity than those without, and a B-ring 3′,4′,5′-trihydroxyl group
further improved their efficacy [103,105]. When C-3’, 4’ positions in B ring of flavonoids
are replaced by hydroxyl groups, the antioxidant activity improved remarkably, however,
the numbers and substitutional positions of methoxyl and glycosyl seemed to have little
effect on the antioxidant activity [106]. In an animal study, C57BL/6J mice were received a
polyphenol-rich grape skin extract (PGE) diet at a dose of 200 mg/kg body weight (BW)/d
for a 3-week, 6-month, and life span [107]. The results of this study showed that lifelong
PGE feeding resulted in a transient, but significant change in the survival curve, although
it did not affect the overall survival rate of the animals [107]. These effects of PGE are
associated with enhanced signal pathways involved in energy homeostasis, antioxidant
defense, and mitochondrial biogenesis, including SIRT stimulation [107].
Second, polyphenols can exert antioxidant activity through regulating endogenous
antioxidant and oxidase enzyme production and activity. As a primary mechanism neu-
tralizing oxidants, two intracellular enzymes, sodium oxide dismutase 1 (SOD1) in cytosol,
and SOD2 in the matrix of mitochondria, quickly convert superoxide to hydrogen peroxide.
Hydrogen peroxide is further deactivated by catalase (CAT) or glutathione peroxidases
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(GSH-Px) to water and oxygen. Numerous studies reported that curcumin (8 mg/kg) [108],
EGCG (100 mg/kg) [109], or quercetin ( 0.027% in the diet) [110] reversed oxidative stress-
caused reduction of GSH and SOD levels in mice or rats. Resveratrol protects against
oxidative damage by increasing expressions of SOD1, CAT, and heme oxygenase-1 (HO-
1) as well as the activity of SOD [111,112]. Similarly, oral administration of epimedium
flavonoids improved CAT and GSH-Px activities by 13.58% and 5.18%, respectively, in
D. melanogaster [113]. Genistein dose-dependently increased GSH-Px in breast cancer
cells [114]. Flavonoid chrysin and its derivatives exhibit a high selectivity of GSH efflux
(transporting intracellular GSH out of the cell), which can be used to kill chemoresistant
cancer cells [115].
Third, polyphenols may enhance cellular antioxidant activity via regulating Nrf2-
mediated pathway. Nrf2 is a transcriptional factor regulating the expression of several
detoxifying enzymes, including SOD, GPx1, GSH, NADP(H) quinone oxidoreductase 1
(NQO1), GST, and HO-1, by binding to the antioxidant-response elements (AREs) in the
promoter regions of the genes of these enzymes [116]. Numerous polyphenols, including
EGCG [117], luteolin [118], curcumin [119], and epicatechin [120] can enhance Nrf2 DNA-
binding activity or protein expression and subsequently increase NQO1, HO-1 and SOD
expression. Resveratrol (25–50 µM) increased 2.5-fold NQO1 protein levels and a 3- to 5-fold
NQO1 enzymatic activity in human k562 cells [121]. The possible molecular mechanism
is that resveratrol disrupts the Nrf2-Keapl complex in the cytosol, which stimulates the
translocation of Nrf2 to the nucleus where it locates the ARE-containing 5’-promoter region
of NQO1, leading to its transcriptional activation [121].
Lastly, there is emerging evidence showing that polyphenols may counteract ROS
via regulating mircoRNAs (miRNA, see more details in the next section). MicroRNAs
(miRNAs) are endogenous, noncoding, single-stranded, and short (19-22 of 22 nucleotides)
RNAs. miRNAs sequence-specifically bind to the 3′UTR of mRNA to repress or induce
translation to regulate diverse biological pathways and processes, including cell death and
proliferation, human diseases like cancer and aging. Up to now, more than 38,589 miRNAs
have been cataloged in miRbase (http://www.mirbase.org, accessed on 1 December 2020),
and nearly 60% of all human transcripts are predicted to be regulated by miRNAs [122]. It
was recently found that some polyphenols, including quercetin, hesperidin, naringenin,
anthocyanin, catechin, and curcumin reversed ApoE mutant-induced changes of miRNAs,
including mmu-miR-291b-5p, mmu-miR-296-5p, mmu-miR-30c-1, mmu-miR-467b, and
mmu-miR-374, which collectively regulate 34 common pathways, including the pathway of
GSH metabolism [123]. Another study found that curcumin downregulated the expression
of miR-17-5p, miR-20A, and miR-27a, which was shown to modulate ROS production [124].
Dietary quercetin supplementation (2 mg/g diet, 6 weeks) increased the expression levels
of hepatic miR-122 and miR-125b in high fat diet-induced obese mice [125], which were
associated with redox factor 1, a modulator of oxidative stress [126]. Therefore, as shown
in Figure 1, polyphenols may protect cells from oxidative stress by multiple mechanisms.
Indeed, it was shown that curcumin could directly scavenge ROS [127], increase the ex-
pression of endogenous antioxidants [108], activate the Nrf2 pathway [119], and modulate
miRNAs [128].
3.2. Polyphenols and Cellular Senescence
3.2.1. Cellular Senescence and Aging
Aging, happening to each living creature, is a complicated degenerative process.
One of the earliest written records of human pursuits for anti-aging drugs can be found
in the earliest Chinese pharmacy monograph, Shennong Materia Medica, in B. C. 220.
Indeed, scientists constantly sought to decipher the driving forces behind aging and
approximately 300 theories of aging have been proposed, however, there is no dominant
one that has been generally accepted by the scientific community to convincingly explain
the aging process [129]. Among the early theories of aging, the activity theory defines
aging as the maintenance of activities and attitudes of the young and middle ages as
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long as possible [130]. The evolutionary theory indicates that aging is not driven by
damage, but causes organelle damage and functional decline [131]. Getting old is a
developmental program, which never stops. The free radical theory proposes that aging
is the result of cumulative damage to DNA, proteins, lipids, and other macromolecules
caused by un-neutralized free radicals [132]. In fact, there is a dynamic balance between
oxidants (ROS, and reactive nitrogen species, RNS) and antioxidants in the body. ROS,
primarily superoxide anion (O2–˙), are primarily produced by mitochondrion during energy
production (about 2% of total oxygen consumption) [133]. Superoxide is quickly converted
to hydrogen peroxide by two intracellular enzymes, SOD1 in cytosol and SOD2 in the
matrix of mitochondria. Hydrogen peroxide is further converted into water and oxygen
by catalase or GPx [134]. Endogenous antioxidant GSH and exogenous antioxidants,
including vitamins C and E, dietary polyphenols are also important ROS scavengers.
Chronic imbalance (extra amount of ROS) between ROS and antioxidants leads to cellular
senescence, functional alterations, and pathological conditions [97,98].
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Figure 1. Schematic diagram of polyphenols antioxidant mechanisms. ROS, reactive oxygen species; Nrf2, nuclear factor
erythroid 2-related factor 2.
Senescence (from the Latin word “senex“, meaning growing old), or cellular aging,
is an irreversible cell-cycle arrest in the G1 phase, elicited by excessive intracellular or
extracellular stress or damage [135,136]. Senescence is necessary to restrict the replication
of old and damaged cells and other detrimental alterations, thereby inactivating potential
malignant transformation [135,137]. Based on the kinetics of cell senescent processes, cel-
lular senescence can be primarily categorized as acute (transient) or chronic (persistent)
senescence. While acute senescence is the part of normal biological processes necessary for
maintaining physiological homeostasis, and has beneficial effect within tissues during em-
bryonic development, wound healing, or tissue repair, chronic senescence has detrimental
effects within cells and tissues, particularly in the elderly because these cells and tissues are
not able to clean damaged cells through autophagic process, and leads to aging and aging-
associated diseases such as cancer [138]. Increasing evidence shows that senescent cells
accumulate in tissues of humans, primates, and rodents with age [139], and accumulation
of senescent cells was also associated with aging-related diseases such as diabetes [140],
Antioxidants 2021, 10, 283 10 of 20
atherosclerosis [141], and obesity [142]. Interestingly, it was shown that oxidative stress is
one of the major inducers of cell senescence [143,144]. Therefore, it is tempting to speculate
that polyphenols as exogenous antioxidants may have the potential to prevent cellular
senescence and thereby the aging process.
3.2.2. The Effects of Polyphenols on Cellular Senescence
Polyphenols treatment has beneficial effects over certain types of disease due to their
action on preventing cellular senescence. A combination treatment with a senolytic drug
Dasatinib and quercetin, a well-studied flavonol present in many plants, reduced the
accumulation of senescent cells in adipose tissue by suppressing the senescence-associated
β-galactosidase activity [145]. In agreement with this in vitro finding, the combination of
Dasatinib and quercetin alleviated senescence-related idiopathic lung fibrosis [146]. In
a senescence mouse model SAMP8 mice, the group consuming a diet with 532 mg/kg
olive oil phenols for 4.5 months showed significantly lower levels of oxidative damage
in the heart and induced longevity-related genes expression as compared to the group
consuming diet with only 44 mg/kg olive oil polyphenols [39]. Consistently, it was shown
that chronic treatment of pre-senescent human lung and neonatal human dermal fibroblasts
with 1 µM hydroxytyrosol or 10 µM oleuropein aglycone effectively reduced senescent
cell numbers as demonstrated by measuring β-galactosidase-positive cell numbers and
p16 protein expression [147]. In line with this finding, oleuropein treatment delayed the
appearance of senescence morphology and extended the life span of human embryonic
fibroblasts IMR90 and WI38 cells by approximately 15% [148]. Gallic acid was reported
to suppress β-galactosidase activity and the expression of oxidative stress markers in rat
embryonic fibroblast cells [149]. These results suggest that polyphenols may be able to
modulate cellular senescence thereby influencing aging process.
3.3. Polyphenols May Exert Anti-Aging Effects by Targeting Microrna
MicroRNAs (miRNAs) are small non-coding RNA molecule secreted from cells into
peripheral body fluids, including blood, saliva, and urine, either in association with RNA-
binding proteins like Argonaute 2, or bound to high-density lipoproteins, and some ‘circu-
latory’ miRNAs have been proposed as noninvasive biomarkers of aging [150]. Numerous
miRNAs have been shown to directly affect lifespan as demonstrated by overexpressing
or knockdown of the miRNA in C. elegans, Drosophila, and mice. These miRNAs, such as
miR-125, miR-17, let-7, AGO1, and AGO2, regulated well-known aging signaling pathways,
including target of rapamycin (TOR), insulin/insulin-like growth-factor (IGF-1) signaling,
sirtuins deacetylases, mitochondrial/ROS signaling, and DNA-damage response [151].
In addition, using cells or mouse models, a number of miRNAs, including miR-1000,
miR-455-3p, miRNA-17/20a, and miR-34a, have been shown to extend longevity through
improving aging-caused dysfunctions of organs such as the brain [152], muscle [153],
bone [154], and heart [155], respectively. However, most studies exploring and identifying
lifespan-modulating miRNAs used C. elegans and Drosophila, and miR-17 is the only miRNA
that has been reported to directly extend lifespan in mice [156].
While studies investigating the effects of polyphenols on miRNA expression are
limited, which is an intriguing area to explore in the future, emerging evidence shows
that dietary intake of some polyphenols modulates the expression of miRNAs that are
involved in longevity. One study found that a low dose of supplementation of quercetin,
hesperidin, naringenin, anthocyanin, catechin, or curcumin (0.006%, w/w, two weeks) in
the diet modulated the expression of a broad range of miRNAs and rectified the ApoE-
mutantation-induced changes of miRNAs in the livers of ApoE-deficient mice [123]. These
polyphenol-modulated miRNAs, including mmu-miR-291b-5p, mmu-miR-296-5p, mmu-
miR-30c-1, mmu-miR-467b, and mmu-miR-374, regulate 30 common pathways, including
MAPK signaling pathway, the calcium signaling pathway, the insulin signaling pathway, as
well as oxidative phosphorylation, some of which are involved in longevity in mice [123].
In addition, miR-17, a mammalian longevity miRNA that directly targets insulin receptor
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substrate (Irs1) and adenylate cyclase 5 (Adcy5), can be regulated by polyphenols. For
instance, catechin, proanthocyanins, naringin [123] and genistein [157] upregulated miR-
17 expression in mice. Similarly, the expression of let-7, a common longevity miRNA
conserved across C. elegans, Drosophila, mouse, and humans, was enhanced by catechin,
proanthocyanins, and naringin in ApoE mice [123]. Therefore, some polyphenols may
act through miRNAs to regulate aging-related pathways, suppress inflammation and
ROS production, and improve lipid metabolism, leading to a healthier and extended
lifespan [128]. The effect of polyphenols on the expression of miRNAs may not be specific.
For instance, epicatechin was shown to modulate more than 73 miRNAs involved in
various cellular functions in human endothelial cells [158]. In diabetic patients, dietary
intake of grape extract (8.1-16.2 mg polyphenols) upregulated miR-21, miR-181b, miR-663,
and miR-30c concomitted with the lower levels of inflammatory cytokines such as IL-6,
chemokine ligand 3, IL-1, and TNF-α [159]. However, it is unclear whether any of these
miRNA directly mediates the anti-inflammatory action of the grape extract.
3.4. Polyphenols and NO Bioavailability
Endothelial dysfunction, resulting from inflammation, obesity, diabetes, hypertension,
hyperlipidemia, and other related metabolic syndromes, is a major pathogenic cause of
cardiovascular disease [160]. Endothelial dysfunction impairs the production and bioavail-
ability of endothelial nitric oxide (NO) synthase (eNOS)-derived NO, which is the key
regulator of vascular tone, blood pressure, and vascular inflammation [161]. The endothe-
lial production and bioavailability of NO also progressively decreases with aging [162],
which is at least partially ascribed to the increased production of ROS [163,164]. In normal
condition, eNOS is coupled to generate NO from oxidation of L-arginine. However, excess
oxidative stress causes the oxidation of tetrahydrobiopterin, a critical cofactor for eNOS,
which leads to eNOS uncoupling from producing NO, but diversion to reduce oxygen to
form superoxide [165,166], thereby reducing the bioavailability of NO that subsequently
accelerates the development of vascular disease [163,164]. Thus, promoting the eNOS
expression/activity and/or NO bioavailability would be effective methods to alleviate
aging-associated endothelial dysfunction and subsequently delay the development of
cardiovascular disease. Plenty of studies have demonstrated that polyphenolic compounds
have protective actions over cardiometabolic syndrome [167], among which eNOS expres-
sion/activity and NO bioavailability are the most determined mechanisms [161,168–170].
Morin, a flavonoid, can effectively protect human ventricular myocytes, saphenous vein
endothelial cells, and erythrocytes against oxyradicals-induced damage [171]. Further,
morin treatment promoted eNOS-mediated NO production and vasodilation of aorta in
STZ-induced diabetic mice by activating the Akt signaling pathway [172,173]. As afore-
mentioned, resveratrol has attracted mounting research interests [174,175]. Resveratrol
treatment increased the eNOS transcriptional activity and the eNOS-derived NO produc-
tion in human umbilical vein endothelial cells [176]. Protocatechuic acid (PCA) is a major
metabolite of green tea polyphenols with a strong antioxidant property [177]. Admin-
istration of PCA (200 mg/kg/day) significantly improved insulin- and IGF-1-induced
vasorelaxation in aging spontaneously hypertensive rats via activating the PI3K/NOS/NO
pathway [178]. Cyanidin-3-glucoside (Cy3G), a typical anthocyanin found in deep-colored
plants [179], has been shown to promote eNOS protein expression and subsequently
increase NO output in bovine artery endothelial cells [170]. Interestingly, multiple polyphe-
nols, including catechin, oleuropein, quercetin, and EGCG, were found to reduce nitrite
to NO in the stomach, suggesting that polyphenols may be a nitrite reductant due to
the hydroxyl groups on the phenol ring [180]. Furthermore, 12 weeks of curcumin sup-
plementation improved resistance artery endothelial function by increasing vascular NO
bioavailability and reducing oxidative stress [181]. In diabetic rats, treatment with green tea
extract, which is primarily composed of EGCG, ameliorated the diabetes-induced reduction
of tetrahydrobiopterin, uncoupling of eNOS, and thus increased NO bioavailability and
reduced oxidative stress [165].
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3.5. Polyphenols May Promote Mitochondrial Function
In addition to the direct action on eNOS expression/activity, polyphenols were re-
ported to activate Sirt1 [182,183], which is an upstream regulator of eNOS [184,185], there-
fore Sirt1-mediated mitochondrial biogenesis might underlie the anti-aging actions of
polyphenols against oxidative stress. Indeed, resveratrol treatment increased mitochondrial
biogenesis in wild-type mice but not eNOS knockout mice [179]. Activation of peroxi-
some proliferator-activated receptor-γ coactivator-1α (PGC-1α), the key regulator in mito-
chondrial biogenesis, has been reported to protect against aging-related diseases [16,185].
In vivo, resveratrol promoted liver PGC-1α activity and significantly extended the lifes-
pan of mice fed a high-calorie diet [186]. In vitro, resveratrol treatment increased adeno-
sine monophosphate (AMP)-activated protein kinase (AMPK) phosphorylation in CHO
cells [186], suggesting the involvement of AMPK/Sirt1 signaling pathway in the action
of resveratrol extending lifespan in mammals. Polyphenols treatment (resveratrol, api-
genin, and S17834, a synthetic polyphenol) have been reported to phosphorylate AMPK in
HepG2 cells, thereby subsequently protecting hepatocytes from high glucose-induced lipid
accumulation [187]. Dysfunctional mitochondria can cause imbalanced ROS accumulation
based on the free radical theory, which may exacerbate the progress of aging. Thus, tar-
geting mitochondrial function can be an effective approach to slow aging. Interestingly,
resveratrol treatment can improve the quality of oocytes from aged cows (>10 years old) by
upregulating mitochondrial biogenesis [188], suggesting a potential mechanism to slow
maternal aging. Hydroxytyrosol, a phenolic compound found in olive oil, effectively in-
creased mitochondria number in 7PA2 cells, a well-established cell model to study AD [189],
suggesting polyphenols may help alleviating the energetic deficit of AD patients.
4. Conclusions and Perspectives
Interest in the use of complementary and alternative medicine, particularly polyphenol-
rich natural products, has increased considerably to improve the health and well-being
of humans for the past two decades. Some polyphenols have even been shown to extend
lifespan in various model organisms. Polyphenols at supraphysiological or higher doses
are well recognized to directly scavenge ROS by donating an electron or hydrogen atom.
However, they may exert antioxidant activity in vivo via other mechanisms as discussed in
this paper, given their relatively poor bioavailability. Aging and aging-related disorders
are complex and certainly influenced by dietary habits and genetic backgrounds. This
review is rather narrow considering the tremendous efforts of researchers investigating
the molecular mechanisms underlying the beneficial actions of polyphenols, however, we
highlighted emerging evidence that may provide new mechanisms underlying the antioxi-
dant and anti-aging actions of polyphenols. While the use of polyphenols in preventing
aging-related disorders has proven to be promising in various model organism-based
studies, the safety and potential health benefits from long-term use of the individual pure
compound in humans are still uncertain. It should be noted that one food may contain
at least several and even hundreds of polyphenols [190], and some diets such as Mediter-
ranean diet have multiple polyphenol-rich foods, which collectively contain 290 different
polyphenols [191,192]. Therefore, it could be misleading to attribute the benefits of con-
suming particular polyphenol-containing foods to the individual polyphenols, which are
often given at much higher doses, particularly in animal and in vitro studies, than those
possibly obtained from consuming the relevant foods or supplements by humans [193]. In
the future, it may be more relevant and interesting to investigate the beneficial effects of
the combination of multiple polyphenols or polyphenol-rich foods, as a combination of
polyphenols may exert synergistic or additive beneficial effects [192,194].
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